E

Emergent Biosolutions

EBS

10.550
USD
-2.16
(-16.99%)
مغلق
حجم التداول
96,967
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
487,799,073
أصول ذات صلة
BLK
-11.67
(-1.33%)
865.44 USD
C
CBOE
2.560
(1.40%)
185.750 USD
CME
2.590
(1.34%)
196.290 USD
GS
-8.70
(-1.71%)
500.30 USD
ICE
-0.570
(-0.38%)
150.970 USD
N
NDAQ
-0.380
(-0.56%)
67.280 USD
N
NTRS
-1.760
(-1.99%)
86.890 USD
R
RJF
-3.830
(-3.30%)
112.150 USD
الأخبار المقالات

العنوان: Emergent Biosolutions

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN(R) and other commercial products.